Press releases
- Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
- Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
- Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference
- Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
Key statistics
As of last trade, Kezar Life Sciences Inc (2KZ:STU) traded at 0.765, 16.79% above the 52 week low of 0.655 set on Nov 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.765 |
---|---|
High | 0.77 |
Low | 0.76 |
Bid | 0.76 |
Offer | 0.795 |
Previous close | 0.755 |
Average volume | 0.00 |
---|---|
Shares outstanding | 72.80m |
Free float | 62.02m |
P/E (TTM) | -- |
Market cap | 61.04m USD |
EPS (TTM) | -1.40 USD |
Data delayed at least 15 minutes, as of Apr 30 2024.
More ▼